eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | chronic pain |
| Comorbidity | C0002766|analgesia |
| Sentences | 8 |
| PubMedID- 23269562 | Conclusions: fixed combination pr oxycodone/naloxone was effective and well tolerated in moderate-to-severe chronic pain in patients with constipation, providing analgesia and relief from bowel dysfunction. |
| PubMedID- 24148358 | Ec have been shown to induce analgesia in preclinical models of acute nociception and chronic pain states. |
| PubMedID- 20370845 | As such, the oral co-administration of oxycodone pr/naloxone pr has been shown to provide an effective analgesia for patients with severe chronic pain, and to significantly reduce the impact of oic (21). |
| PubMedID- 24069332 | Previous research has shown that chronic pain or stress lead to enhanced opiate analgesia [36,66,67], potentially mediated by changes in mu receptor expression, localization or activity under these circumstances [34,63,64,68-70]. |
| PubMedID- 21887118 | Tapentadol extended-release was found to provide safe and highly effective analgesia for the treatment of chronic pain conditions, including moderate-to-severe chronic osteoarthritis pain and low back pain. |
| PubMedID- 22786458 | Dysfunctional endogenous analgesia during exercise in patients with chronic pain: to exercise or not to exercise. |
| PubMedID- 22484179 | Despite promise, the current state of results alludes to the possibility that cerebral neuromodulation has thus far not been effective in producing analgesia as intended in patients with chronic pain disorders. |
| PubMedID- 20920236 | Indeed, oral co-administration of oxycodone pr/naloxone pr in a 2:1 ratio provides effective analgesia for patients with severe chronic pain while significantly improving oic [21]. |
Page: 1